 Daniel Colon Hidalgo
Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Shock, Septic | 3 | 2021 | 216 | 1.240 |
Why?
| | Pulmonary Medicine | 1 | 2024 | 78 | 0.810 |
Why?
| | Critical Care | 2 | 2024 | 695 | 0.770 |
Why?
| | Spirometry | 1 | 2023 | 231 | 0.750 |
Why?
| | Cardiovascular System | 1 | 2023 | 136 | 0.690 |
Why?
| | Waiting Lists | 1 | 2023 | 263 | 0.690 |
Why?
| | Racism | 1 | 2023 | 155 | 0.640 |
Why?
| | Lung Transplantation | 1 | 2023 | 329 | 0.620 |
Why?
| | Vasoconstrictor Agents | 2 | 2021 | 144 | 0.620 |
Why?
| | Quality of Health Care | 1 | 2024 | 692 | 0.600 |
Why?
| | Minority Groups | 1 | 2021 | 283 | 0.600 |
Why?
| | Tissue and Organ Procurement | 1 | 2023 | 341 | 0.600 |
Why?
| | Vasopressins | 1 | 2019 | 60 | 0.590 |
Why?
| | Education, Medical, Graduate | 1 | 2024 | 562 | 0.590 |
Why?
| | Bacteremia | 1 | 2021 | 222 | 0.590 |
Why?
| | Norepinephrine | 1 | 2019 | 196 | 0.570 |
Why?
| | Hypotension | 1 | 2019 | 126 | 0.560 |
Why?
| | Faculty, Medical | 1 | 2021 | 301 | 0.550 |
Why?
| | Heart Arrest | 1 | 2021 | 406 | 0.520 |
Why?
| | Time-to-Treatment | 1 | 2019 | 242 | 0.520 |
Why?
| | Lung Diseases, Interstitial | 1 | 2023 | 660 | 0.500 |
Why?
| | Inositol | 1 | 2026 | 25 | 0.470 |
Why?
| | Hypoxia | 3 | 2026 | 1193 | 0.460 |
Why?
| | Docosahexaenoic Acids | 1 | 2026 | 83 | 0.450 |
Why?
| | Healthcare Disparities | 3 | 2023 | 736 | 0.440 |
Why?
| | Sepsis | 1 | 2021 | 643 | 0.430 |
Why?
| | Superoxide Dismutase | 2 | 2025 | 303 | 0.390 |
Why?
| | Bipolar Disorder | 1 | 2026 | 278 | 0.380 |
Why?
| | Etomidate | 1 | 2020 | 18 | 0.330 |
Why?
| | Adrenal Insufficiency | 1 | 2020 | 28 | 0.320 |
Why?
| | Oximetry | 1 | 2021 | 125 | 0.310 |
Why?
| | Coinfection | 1 | 2020 | 141 | 0.290 |
Why?
| | Platelet Activation | 2 | 2026 | 98 | 0.280 |
Why?
| | Cross Infection | 1 | 2020 | 263 | 0.270 |
Why?
| | Retrospective Studies | 9 | 2023 | 17147 | 0.260 |
Why?
| | Receptors, Interferon | 1 | 2026 | 60 | 0.230 |
Why?
| | Blood Platelets | 2 | 2026 | 379 | 0.220 |
Why?
| | Pneumonia, Staphylococcal | 1 | 2025 | 27 | 0.220 |
Why?
| | United States | 4 | 2024 | 16018 | 0.220 |
Why?
| | Academic Performance | 1 | 2024 | 15 | 0.210 |
Why?
| | School Admission Criteria | 1 | 2024 | 35 | 0.210 |
Why?
| | Hypertension, Pulmonary | 2 | 2026 | 1948 | 0.210 |
Why?
| | Cell Communication | 1 | 2025 | 325 | 0.190 |
Why?
| | Personnel Selection | 1 | 2024 | 93 | 0.190 |
Why?
| | Hyaluronic Acid | 1 | 2025 | 223 | 0.190 |
Why?
| | Humans | 17 | 2026 | 144665 | 0.180 |
Why?
| | Troponin | 1 | 2021 | 49 | 0.180 |
Why?
| | Fellowships and Scholarships | 1 | 2024 | 355 | 0.160 |
Why?
| | Creatinine | 1 | 2021 | 509 | 0.150 |
Why?
| | After-Hours Care | 1 | 2019 | 16 | 0.150 |
Why?
| | Retinal Photoreceptor Cell Outer Segment | 1 | 2019 | 2 | 0.150 |
Why?
| | Health Status Disparities | 1 | 2023 | 318 | 0.150 |
Why?
| | Quality-Adjusted Life Years | 1 | 2019 | 122 | 0.150 |
Why?
| | Neutrophils | 1 | 2025 | 1118 | 0.150 |
Why?
| | Down Syndrome | 1 | 2026 | 522 | 0.150 |
Why?
| | Blood Coagulation Factors | 1 | 2019 | 60 | 0.150 |
Why?
| | Arterial Pressure | 1 | 2019 | 133 | 0.140 |
Why?
| | Fluid Therapy | 1 | 2019 | 148 | 0.140 |
Why?
| | Retinal Diseases | 1 | 2019 | 101 | 0.140 |
Why?
| | Vitamins | 1 | 2019 | 176 | 0.130 |
Why?
| | Curriculum | 1 | 2024 | 1063 | 0.130 |
Why?
| | Macrophages | 1 | 2025 | 1496 | 0.130 |
Why?
| | Polyps | 1 | 2017 | 14 | 0.130 |
Why?
| | Vitamin D Deficiency | 1 | 2019 | 187 | 0.120 |
Why?
| | Pharmacists | 1 | 2019 | 240 | 0.120 |
Why?
| | Resuscitation | 1 | 2019 | 310 | 0.120 |
Why?
| | Cost-Benefit Analysis | 1 | 2019 | 638 | 0.120 |
Why?
| | Socioeconomic Factors | 1 | 2021 | 1322 | 0.120 |
Why?
| | Choroid | 1 | 2017 | 80 | 0.120 |
Why?
| | Choroidal Neovascularization | 1 | 2017 | 56 | 0.120 |
Why?
| | Myo-Inositol-1-Phosphate Synthase | 1 | 2026 | 3 | 0.120 |
Why?
| | Bone and Bones | 1 | 2019 | 317 | 0.120 |
Why?
| | Health Care Costs | 1 | 2019 | 425 | 0.120 |
Why?
| | Phosphoric Monoester Hydrolases | 1 | 2026 | 56 | 0.110 |
Why?
| | Vitamin D | 1 | 2019 | 400 | 0.110 |
Why?
| | Medicare | 1 | 2021 | 899 | 0.110 |
Why?
| | Incidence | 1 | 2021 | 2892 | 0.110 |
Why?
| | Tomography, Optical Coherence | 1 | 2017 | 270 | 0.110 |
Why?
| | Burns | 1 | 2019 | 371 | 0.100 |
Why?
| | Aged | 4 | 2021 | 25955 | 0.090 |
Why?
| | Calcium | 1 | 2019 | 1182 | 0.090 |
Why?
| | Hypertension | 1 | 2021 | 1262 | 0.090 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2026 | 418 | 0.090 |
Why?
| | Saccharomyces cerevisiae | 1 | 2026 | 579 | 0.080 |
Why?
| | Time Factors | 2 | 2019 | 7140 | 0.080 |
Why?
| | Adult | 5 | 2026 | 40486 | 0.080 |
Why?
| | Diagnostic Errors | 1 | 2021 | 177 | 0.080 |
Why?
| | Hypnotics and Sedatives | 1 | 2020 | 216 | 0.070 |
Why?
| | Intubation, Intratracheal | 1 | 2020 | 323 | 0.070 |
Why?
| | Risk Factors | 1 | 2021 | 10796 | 0.060 |
Why?
| | Emergency Service, Hospital | 1 | 2019 | 2325 | 0.060 |
Why?
| | Oxygen | 1 | 2021 | 984 | 0.060 |
Why?
| | Neutrophil Infiltration | 1 | 2025 | 104 | 0.050 |
Why?
| | Vascular Remodeling | 1 | 2026 | 203 | 0.050 |
Why?
| | Mice, Inbred C57BL | 2 | 2025 | 5967 | 0.050 |
Why?
| | Mice | 3 | 2026 | 18261 | 0.050 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2025 | 264 | 0.050 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2025 | 441 | 0.050 |
Why?
| | Lung | 2 | 2026 | 4089 | 0.050 |
Why?
| | Staphylococcus aureus | 1 | 2025 | 454 | 0.040 |
Why?
| | Extracellular Matrix | 1 | 2025 | 560 | 0.040 |
Why?
| | Internship and Residency | 1 | 2021 | 1262 | 0.040 |
Why?
| | Mice, Transgenic | 1 | 2025 | 2184 | 0.040 |
Why?
| | Vitamin D-Binding Protein | 1 | 2019 | 15 | 0.040 |
Why?
| | Retinal Pigment Epithelium | 1 | 2019 | 79 | 0.040 |
Why?
| | Animals | 3 | 2026 | 37948 | 0.040 |
Why?
| | Statistics, Nonparametric | 1 | 2019 | 427 | 0.030 |
Why?
| | Chi-Square Distribution | 1 | 2019 | 524 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2025 | 1338 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2025 | 3109 | 0.030 |
Why?
| | Male | 5 | 2026 | 72425 | 0.030 |
Why?
| | Antihypertensive Agents | 1 | 2021 | 512 | 0.030 |
Why?
| | Fundus Oculi | 1 | 2017 | 89 | 0.030 |
Why?
| | Acute Disease | 1 | 2019 | 1029 | 0.030 |
Why?
| | Respiration, Artificial | 1 | 2021 | 710 | 0.030 |
Why?
| | Fluorescein Angiography | 1 | 2017 | 190 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2019 | 8283 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2026 | 4539 | 0.030 |
Why?
| | Dietary Supplements | 1 | 2019 | 575 | 0.030 |
Why?
| | Anticoagulants | 1 | 2019 | 729 | 0.030 |
Why?
| | Hemorrhage | 1 | 2019 | 813 | 0.030 |
Why?
| | Inflammation | 1 | 2025 | 2870 | 0.020 |
Why?
| | Child | 2 | 2026 | 22599 | 0.020 |
Why?
| | Critical Illness | 1 | 2019 | 888 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2019 | 5414 | 0.020 |
Why?
| | Female | 3 | 2026 | 78301 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2017 | 3414 | 0.020 |
Why?
| | Cohort Studies | 1 | 2019 | 5957 | 0.020 |
Why?
| | Prospective Studies | 1 | 2019 | 7994 | 0.020 |
Why?
| | Middle Aged | 2 | 2019 | 35968 | 0.010 |
Why?
|
|
Colon Hidalgo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|